Detrusan is a revolution in the treatment of female urinary incontinence.

Detrusan is a revolutionary new treatment for female urge and stress urinary incontinence. Urinary incontinence can be caused by childbirth, old-age, accidents or surgery and afflicts over 50 million women of all ages in the developed world.

Detrusan utilizes groundbreaking neuromodulation technology and has been clinically proven to deliver real and lasting improvement in trials with over 500 patients in leading US hospitals.

Detrusan has demonstrated leading safety and efficacy and is CE-marked for sale in the EU. If you are a patient or potential clinical partner and would like to know more about Detrusan, please contact us at: